Roeser Group, a Bochum, Germany-based distributor of medical supplies to hospitals, has received a private equity investment of undisclosed amount from EQT Expansion Capital II.
EQT Expansion Capital II, which supported the management buyout of Roeser Group, will help the new majority owners further extend the company’s position as market leader in Germany and grow internationally.
Through its two business divisions, Roeser Medical and Hospigate, the company offers tailor-made distribution solutions, including consulting, logistics and procurement services. Roeser currently employs 300 people and works with over 900 suppliers, providing more than 800,000 different articles to its customers.
Commenting on the investment, Dr. Joachim Mohme, shareholder and Managing Director of Roeser, was quoted as saying: “We are delighted to have EQT Expansion Capital on board.
“They will provide us with network and know how, as well as resources to further develop the company as the leading player in Germany and to increase our international business”.
In conjunction with the deal, a new board of directors has been appointed. It will include the following members from EQT’s network of industrial advisors:
– Werner Spinner, Chairman – former member of the management board of Bayer AG, supervisory board member of CSM and Altana;
– Peter Zuellig – founder and Executive Director of pharmaceutical distributor Parazelsus, former Executive Director of Interpacific.
EQT is a private equity group with investments in Northern and Eastern Europe, Asia and the US, with specialized funds active within buyouts, growth financing and infrastructure.
Its EQT Expansion Capital II is a €474m fund providing capital for privately owned mid-market companies.